Evidence for a neuromuscular circuit involving hypothalamic interleukin-6 in the control of skeletal muscle metabolism.
Carlos Kiyoshi KatashimaThayana de Oliveira MichelettiRenata Rosseto BragaRodrigo Stellzer GasparLudger J E GoeminneAlexandre Moura-AssisBarbara Moreira CrisolRafael S BrícolaVagner Ramon R SilvaCamila de Oliveira RamosAlisson Luiz da RochaMariana Rosolen TavaresFernando Moreira SimabucoValquíria Aparecida MatheusLucas BuscarattiHenrique Marques-SouzaPatricia PazosDavid Gonzalez-ToucedaSulay TovarMaría Del Carmen GarcíaJose Cesar Rosa NetoRui CuriSandro Massao HirabaraPatrícia Chakur BrumPatrícia Oliveira PradaLeandro P de MouraJosé Rodrigo PauliAdelino Sanchez Ramos da SilvaDennys Esper Corrêa CintraLicio A VellosoEduardo Rochete RopellePublished in: Science advances (2022)
Hypothalamic interleukin-6 (IL6) exerts a broad metabolic control. Here, we demonstrated that IL6 activates the ERK1/2 pathway in the ventromedial hypothalamus (VMH), stimulating AMPK/ACC signaling and fatty acid oxidation in mouse skeletal muscle. Bioinformatics analysis revealed that the hypothalamic IL6/ERK1/2 axis is closely associated with fatty acid oxidation- and mitochondrial-related genes in the skeletal muscle of isogenic BXD mouse strains and humans. We showed that the hypothalamic IL6/ERK1/2 pathway requires the α2-adrenergic pathway to modify fatty acid skeletal muscle metabolism. To address the physiological relevance of these findings, we demonstrated that this neuromuscular circuit is required to underpin AMPK/ACC signaling activation and fatty acid oxidation after exercise. Last, the selective down-regulation of IL6 receptor in VMH abolished the effects of exercise to sustain AMPK and ACC phosphorylation and fatty acid oxidation in the muscle after exercise. Together, these data demonstrated that the IL6/ERK axis in VMH controls fatty acid metabolism in the skeletal muscle.
Keyphrases